Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 110

1.

Increasing Heme Oxygenase-1-Expressing Macrophages Indicates a Tendency of Poor Prognosis in Advanced Colorectal Cancer.

Kimura S, Aung NY, Ohe R, Yano M, Hashimoto T, Fujishima T, Kimura W, Yamakawa M.

Digestion. 2019 May 21:1-10. doi: 10.1159/000500225. [Epub ahead of print]

PMID:
31112982
2.

Synthesis and characterization of 20-hydroxyvitamin D3 with the A-ring modification.

Fujishima T, Suenaga T, Kawahata M, Yamaguchi K.

J Steroid Biochem Mol Biol. 2019 Mar;187:27-33. doi: 10.1016/j.jsbmb.2018.10.019. Epub 2018 Oct 30.

PMID:
30389627
3.

Evaluating effectiveness of infection control efforts in hospitals using information in microbiological laboratory databases.

Saito N, Itoga M, Kimura M, Inoue F, Minakawa S, Kimura T, Ozaki H, Saito Y, Takahashi M, Fujishima T, Mizuno S, Ogawa S, Kitayama Y, Kudo K, Minami K, Abo F, Takano Y, Ohdaira N, Hamada S, Ueki S, Hirokawa M, Kayaba H.

J Gen Fam Med. 2017 Jun 15;18(6):354-359. doi: 10.1002/jgf2.93. eCollection 2017 Dec.

4.
5.

Synthetic strategy and biological activity of A-ring stereoisomers of 1,25- dihydroxyvitamin D3 and C2-modified analogues.

Fujishima T, Suenaga T, Nozaki T.

Curr Top Med Chem. 2014;14(21):2446-53. Review.

PMID:
25486939
6.

Synthesis and biological evaluation of 1α,25-dihydroxyvitamin D3 analogues with aromatic side chains attached at C-17.

Liu C, Zhao GD, Mao X, Suenaga T, Fujishima T, Zhang CM, Liu ZP.

Eur J Med Chem. 2014 Oct 6;85:569-75. doi: 10.1016/j.ejmech.2014.08.031. Epub 2014 Aug 9.

PMID:
25127149
7.

Changes of seasonal morph development induced by surgical operations in pupae of the large map butterfly Araschnia burejana Bermer (Lepidoptera: Nymphalidae).

Yamashita K, Kanzaki K, Hinauchi M, Fujishima T, Islam AT, Kitazawa C, Endo K, Yamanaka A.

J Exp Zool A Ecol Genet Physiol. 2014 Jun;321(5):276-82. doi: 10.1002/jez.1862. Epub 2014 Mar 26.

PMID:
24668770
8.

Design and synthesis of novel 1,25-dihydroxyvitamin D3 analogues having a spiro-oxetane fused at the C2 position in the A-ring.

Fujishima T, Nozaki T, Suenaga T.

Bioorg Med Chem. 2013 Sep 1;21(17):5209-17. doi: 10.1016/j.bmc.2013.06.032. Epub 2013 Jun 20.

PMID:
23845283
9.

Mass infection with Entamoeba histolytica in a Japanese institution for individuals with mental retardation: epidemiology and control measures.

Nishise S, Fujishima T, Kobayashi S, Otani K, Nishise Y, Takeda H, Kawata S.

Ann Trop Med Parasitol. 2010 Jul;104(5):383-90. doi: 10.1179/136485910X12743554760388.

PMID:
20819306
10.

Difficulties in the treatment of intestinal amoebiasis in mentally disabled individuals at a rehabilitation institution for the intellectually impaired in Japan.

Fujishima T, Nishise S, Ichihara M, Kobayashi S, Takeuchi T.

Chemotherapy. 2010;56(4):348-52. doi: 10.1159/000320187. Epub 2010 Aug 18.

PMID:
20720419
11.

Novel vitamin D receptor ligands having a carboxyl group as an anchor to arginine 274 in the ligand-binding domain.

Fujishima T, Tsuji G, Tanaka C, Harayama H.

J Steroid Biochem Mol Biol. 2010 Jul;121(1-2):60-2. doi: 10.1016/j.jsbmb.2010.04.020. Epub 2010 May 6.

PMID:
20435140
12.

Synthesis of 2alpha-propoxy-1alpha,25-dihydroxyvitamin D3 and comparison of its metabolism by human CYP24A1 and rat CYP24A1.

Saito N, Suhara Y, Abe D, Kusudo T, Ohta M, Yasuda K, Sakaki T, Honzawa S, Fujishima T, Kittaka A.

Bioorg Med Chem. 2009 Jul 1;17(13):4296-301. doi: 10.1016/j.bmc.2009.05.032. Epub 2009 May 18.

PMID:
19482479
13.

Light propagation from a fluorescent particle embedded in a photonic cluster of micrometer-sized dielectric spheres.

Fujishima T, Miyazaki HT, Miyazaki H, Jimba Y, Kasaya T, Sakoda K, Ogawa Y, Minami F.

Opt Express. 2008 Dec 8;16(25):20706-23.

PMID:
19065210
14.

In vivo silencing of a molecular target by short interfering RNA electroporation: tumor vascularization correlates to delivery efficiency.

Takei Y, Nemoto T, Mu P, Fujishima T, Ishimoto T, Hayakawa Y, Yuzawa Y, Matsuo S, Muramatsu T, Kadomatsu K.

Mol Cancer Ther. 2008 Jan;7(1):211-21. doi: 10.1158/1535-7163.MCT-07-0319.

15.

[Successful treatment by voriconazole for pulmonary aspergilloma of elderly patient].

Hashimoto M, Honda Y, Fujishima T.

Nihon Kokyuki Gakkai Zasshi. 2007 Dec;45(12):957-61. Japanese.

PMID:
18186242
16.

Changes in hepatic functional reserve after percutaneous tumor ablation for hepatocellular carcinoma: long-term follow up for 227 consecutive patients with a single lesion.

Koike Y, Yoshida H, Shiina S, Teratani T, Obi S, Sato S, Akamatsu M, Tateishi R, Fujishima T, Hoshida Y, Kanda M, Ishikawa T, Shiratori Y, Omata M.

Hepatol Int. 2007 Jun;1(2):295-301. doi: 10.1007/s12072-007-9001-x.

17.

Age-related comparison of the profiles of patients with hepatocellular carcinoma.

Fujishima T, Ishikawa T, Shiratori Y, Kanda M, Tateishi R, Akamatsu M, Koike Y, Sato S, Obi S, Hamamura K, Teratani T, Shiina S, Yoshida H, Kawabe T, Omata M.

Hepatogastroenterology. 2006 Nov-Dec;53(72):913-8.

PMID:
17153452
18.

Electrochemistry of redox-modified oligonucleotides bound to gold surface.

Kawakami N, Fujishima T, Nakamura M, Yamana K.

Nucleic Acids Symp Ser (Oxf). 2004;(48):247-8.

PMID:
17150571
19.

[Traumatic diaphragmatic hernia presenting with shock 1 year after blunt injury; report of a case].

Kanauchi N, Fujishima T, Oizumi H.

Kyobu Geka. 2006 Nov;59(12):1123-6. Japanese.

PMID:
17094555
20.

Probing a water channel near the A-ring of receptor-bound 1 alpha,25-dihydroxyvitamin D3 with selected 2 alpha-substituted analogues.

Hourai S, Fujishima T, Kittaka A, Suhara Y, Takayama H, Rochel N, Moras D.

J Med Chem. 2006 Aug 24;49(17):5199-205.

PMID:
16913708
21.

Methyl-introduced A-ring analogues of 1alpha,25-dihydroxyvitamin D3: synthesis and biological evaluation.

Fujishima T, Tsutsumi R, Negishi Y, Fujii S, Takayama H, Kittaka A, Kurihara M.

Anticancer Res. 2006 Jul-Aug;26(4A):2633-6.

22.

A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma.

Shiina S, Teratani T, Obi S, Sato S, Tateishi R, Fujishima T, Ishikawa T, Koike Y, Yoshida H, Kawabe T, Omata M.

Gastroenterology. 2005 Jul;129(1):122-30.

PMID:
16012942
23.

The antagonism between 2-methyl-1,25-dihydroxyvitamin D3 and 2-methyl-20-epi-1,25-dihydroxyvitamin D3 in non-genomic pathway-mediated biological responses induced by 1alpha,25-dihydroxyvitamin D3 assessed by NB4 cell differentiation.

Miura D, Norman AW, Mizwicki MT, Fujishima T, Konno K, Kittaka A, Takayama H, Ishizuka S.

J Steroid Biochem Mol Biol. 2005 Apr;94(5):469-79. Epub 2005 Mar 17.

PMID:
15876412
24.

Analysis of factors influencing hepatocellular carcinoma detection: efficient use of computed tomography during arterial portography and during hepatic arteriography.

Fujishima T, Yoshida H, Obi S, Shiina S, Kanda M, Tateishi R, Akamatsu M, Koike Y, Sato S, Teratani T, Kawabe T, Shiratori Y, Omata M.

J Gastroenterol. 2005 Mar;40(3):266-73.

PMID:
15830286
25.

Factors predisposing to poorly differentiated hepatocellular carcinoma and its recurrence.

Akamatsu M, Ishikawa T, Shiratori Y, Koike Y, Shiina S, Teratani T, Hamamura K, Obi S, Sato S, Tateishi R, Fujishima T, Imai Y, Yoshida H, Omata M.

Hepatogastroenterology. 2005 Mar-Apr;52(62):391-7.

PMID:
15816443
26.

Metabolism of 2 alpha-propoxy-1 alpha,25-dihydroxyvitamin D3 and 2 alpha-(3-hydroxypropoxy)-1 alpha,25-dihydroxyvitamin D3 by human CYP27A1 and CYP24A1.

Abe D, Sakaki T, Kusudo T, Kittaka A, Saito N, Suhara Y, Fujishima T, Takayama H, Hamamoto H, Kamakura M, Ohta M, Inouye K.

Drug Metab Dispos. 2005 Jun;33(6):778-84. Epub 2005 Mar 11.

PMID:
15764712
27.

Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients.

Tateishi R, Yoshida H, Shiina S, Imamura H, Hasegawa K, Teratani T, Obi S, Sato S, Koike Y, Fujishima T, Makuuchi M, Omata M.

Gut. 2005 Mar;54(3):419-25.

28.

Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases.

Tateishi R, Shiina S, Teratani T, Obi S, Sato S, Koike Y, Fujishima T, Yoshida H, Kawabe T, Omata M.

Cancer. 2005 Mar 15;103(6):1201-9.

29.

Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial.

Akamatsu M, Yoshida H, Obi S, Sato S, Koike Y, Fujishima T, Tateishi R, Imamura M, Hamamura K, Teratani T, Shiina S, Ishikawa T, Omata M.

Liver Int. 2004 Dec;24(6):625-9.

PMID:
15566514
30.

A novel display of reconstruction computed tomography for the detection of small hepatocellular carcinoma.

Teratani T, Yoshida H, Shiina S, Obi S, Sato S, Koike Y, Hamamura K, Akamatsu M, Fujishima T, Imai Y, Kawabe T, Shiratori Y, Omata M.

Liver Int. 2004 Dec;24(6):619-24. Erratum in: Liver Int. 2005 Feb;25(1):196. Haruhiko, Yoshida [corrected to Yoshida, Haruhiko]; Shuichiro, Shiina [corrected to Shiina, Shuichiro]; Shuntaro, Obi [corrected to Obi, Shuntaro]; Shinpei, Sato [corrected to Sato, Shinpei]; Yukihiro, Koike [corrected to Koike, Yukihiro]; Keisuke, Hamamur.

PMID:
15566513
31.

Design and efficient synthesis of 2 alpha-(omega-hydroxyalkoxy)-1 alpha,25-dihydroxyvitamin D3 Analogues, including 2-epi-ED-71 and their 20-epimers with HL-60 cell differentiation activity.

Saito N, Suhara Y, Kurihara M, Fujishima T, Honzawa S, Takayanagi H, Kozono T, Matsumoto M, Ohmori M, Miyata N, Takayama H, Kittaka A.

J Org Chem. 2004 Oct 29;69(22):7463-71.

PMID:
15497970
32.

Metabolism of A-ring diastereomers of 1alpha,25-dihydroxyvitamin D3 by CYP24A1.

Kusudo T, Sakaki T, Abe D, Fujishima T, Kittaka A, Takayama H, Hatakeyama S, Ohta M, Inouye K.

Biochem Biophys Res Commun. 2004 Sep 3;321(4):774-82.

PMID:
15358094
33.

2,2-Functionalized analogues of 1alpha,25-dihydroxyvitamin D3, the potent inducers of cell differentiation.

Fujishima T, Kittaka A, Kurihara M, Saito N, Honzawa S, Kishimoto S, Sugiura T, Waku K, Takayama H.

J Steroid Biochem Mol Biol. 2004 May;89-90(1-5):89-92.

PMID:
15225752
34.

FT-Raman spectroscopy of calcium hydroxide medicament in root canals.

Kwon TY, Fujishima T, Imai Y.

Int Endod J. 2004 Jul;37(7):489-93.

PMID:
15189439
35.

Neither hepatitis C virus genotype nor virus load affects survival of patients with hepatocellular carcinoma.

Akamatsu M, Yoshida H, Shiina S, Teratani T, Tateishi R, Obi S, Sato S, Koike Y, Fujishima T, Ishikawa T, Shiratori Y, Omata M.

Eur J Gastroenterol Hepatol. 2004 May;16(5):459-66.

PMID:
15097037
36.

Clinical features of patients with HCC who are negative for both HBV and HCV markers.

Watabe H, Shiratori Y, Tateishi R, Fujishima T, Akamatsu M, Koike Y, Obi S, Hamamura K, Sato S, Teratani T, Shiina S, Omata M.

Hepatogastroenterology. 2003 Nov-Dec;50(54):2157-60.

PMID:
14696486
37.

Remarkable effect of 2[small alpha]-modification on the VDR antagonistic activity of 1small alpha-hydroxyvitamin D3-26,23-lactones.

Saito N, Matsunaga T, Fujishima T, Anzai M, Saito H, Takenouchi K, Miura D, Ishizuka S, Takayama H, Kittaka A.

Org Biomol Chem. 2003 Dec 21;1(24):4396-402. Epub 2003 Nov 6.

PMID:
14685312
38.

Dramatic enhancement of antagonistic activity on vitamin D receptor: a double functionalization of 1alpha-hydroxyvitamin D3 26,23-lactones.

Saito N, Saito H, Anzai M, Yoshida A, Fujishima T, Takenouchi K, Miura D, Ishizuka S, Takayama H, Kittaka A.

Org Lett. 2003 Dec 11;5(25):4859-62.

PMID:
14653692
39.

Concise synthesis and biological activities of 2alpha-alkyl- and 2alpha-(omega-hydroxyalkyl)-20-epi-1alpha,25-dihydroxyvitamin D3.

Honzawa S, Suhara Y, Nihei K, Saito N, Kishimoto S, Fujishima T, Kurihara M, Sugiura T, Waku K, Takayama H, Kittaka A.

Bioorg Med Chem Lett. 2003 Oct 20;13(20):3503-6.

PMID:
14505658
40.

Metabolism of 20-epimer of 1alpha,25-dihydroxyvitamin D3 by CYP24: species-based difference between humans and rats.

Kusudo T, Sakaki T, Abe D, Fujishima T, Kittaka A, Takayama H, Ohta M, Inouye K.

Biochem Biophys Res Commun. 2003 Oct 3;309(4):885-92.

PMID:
13679056
41.

Efficient synthesis of 2-modified 1alpha,25-dihydroxy-19-norvitamin D3 with Julia olefination: high potency in induction of differentiation on HL-60 cells.

Ono K, Yoshida A, Saito N, Fujishima T, Honzawa S, Suhara Y, Kishimoto S, Sugiura T, Waku K, Takayama H, Kittaka A.

J Org Chem. 2003 Sep 19;68(19):7407-15.

PMID:
12968893
42.

Synthesis of 2,2-dimethyl-1,25-dihydroxyvitamin D3: A-ring structural motif that modulates interactions of vitamin D receptor with transcriptional coactivators.

Fujishima T, Kittaka A, Yamaoka K, Takeyama K, Kato S, Takayama H.

Org Biomol Chem. 2003 Jun 7;1(11):1863-9.

PMID:
12945766
43.

Probing DNA sequences by anthraquinone-modified DNA that is immobilized on gold surface.

Kumamoto S, Kawakami N, Fujishima T, Ohtsuka T, Yamana K, Nakano H, Sugie Y.

Nucleic Acids Res Suppl. 2002;(2):39-40.

PMID:
12903094
44.
45.

Design, synthesis, and biological studies of the A-ring-modified 1,25-dihydroxyvitamin D3 analogs.

Takayama H, Kittaka A, Fujishima T, Suhara Y.

Recent Results Cancer Res. 2003;164:289-317. Review.

PMID:
12899530
46.

Congenital absence of portal vein with multiple hyperplastic nodular lesions in the liver.

Tanaka Y, Takayanagi M, Shiratori Y, Imai Y, Obi S, Tateishi R, Kanda M, Fujishima T, Akamatsu M, Koike Y, Hamamura K, Teratani T, Ishikawa T, Shiina S, Kojiro M, Omata M.

J Gastroenterol. 2003;38(3):288-94. Review.

PMID:
12673454
47.

Photorefractive effect in the relaxor ferroelectric material 0.91Pb(Zn1/3Nb2/3)O3-0.09PbTiO3.

Abe S, Fujishima T, Tsubone T, Fujimura R, Ono H, Matoba O, Oda K, Shimura T, Kuroda K.

Opt Lett. 2003 Mar 15;28(6):420-2.

PMID:
12659266
48.

A novel support system for patient immobilization and transportation for daily computed tomographic localization of target prior to radiation therapy.

Nemoto K, Seiji K, Sasaki K, Kasamatsu N, Fujishima T, Ogawa Y, Ariga H, Takeda K, Kimura T, Yamada S.

Int J Radiat Oncol Biol Phys. 2003 Mar 15;55(4):1102-8.

PMID:
12605990
49.

Assessment of differentiation in adenocarcinoma cells from pleural effusion by peripheral airway cell markers and their diagnostic values.

Takezawa C, Takahashi H, Fujishima T, Shiratori M, Morita Y, Sano H, Kuroki Y, Abe S.

Lung Cancer. 2002 Dec;38(3):273-81.

PMID:
12445749
50.

Design and efficient synthesis of new stable 1alpha,25-dihydroxy-19-norvitamin D3 analogues containing amide bond.

Suhara Y, Kittaka A, Ono K, Kurihara M, Fujishima T, Yoshida A, Takayama H.

Bioorg Med Chem Lett. 2002 Dec 16;12(24):3533-6.

PMID:
12443770

Supplemental Content

Loading ...
Support Center